Biotech2 months ago
Novo Nordisk’s Weight-Loss Pill Moves Ahead, Despite Some Serious Side Effects
Novo Nordisk's experimental weight-loss pill, amycretin, showed promising early-phase results, with patients losing up to 13.1% of their weight in 12 weeks. Side effects were mild...